Storm Therapeutics

Storm Therapeutics, is a spin-out company from the University of Cambridge’s Gurdon Institute focused on the identification and development of small molecule drugs that target RNA-modifying enzymes, opening up novel therapeutic targets in cancer treatment. Storm Therapeutics is based in Cambridge, UK.

http://www.stormtherapeutics.com

Team Member
more about
Hakan Goker
Latest News Entry
2017/02/24
Storm Therapeutics appoints CEO and Chairman

CAMBRIDGE, UK (24 FEB 2017) - Storm Therapeutics, the drug discovery company focused on the discovery of small molecule therapies from RNA epigenetics, moved to the next stage of its development with the appointment of Keith Blundy as Chief Executive Officer and Tim Edwards as Chairman.

all portfolio news